Patients For Affordable Drugs: Join The Fight To Lower Drug Prices

Patients For Affordable Drugs: The National Movement Fighting for Fair Prescription Drug Prices

Prescription drugs don’t work if people can’t afford them — and for millions of Americans, that’s the reality. Patients For Affordable Drugs (P4AD) is the only national, bipartisan patient organization focused exclusively on lowering prescription drug prices. The group refuses funding from any organization that profits from drug development or distribution, ensuring its advocacy is driven solely by patients’ needs.

Why the Fight Matters

Across the United States, families are forced to choose between life‑saving medications and basic necessities. Cancer drugs cost an average of $74,000 more than non‑cancer drugs, and Americans spent $98 billion out of pocket on prescriptions in 2024 — a 25% increase in just five years. These numbers reflect a system where high launch prices, patent abuses, and opaque middlemen drive costs ever higher.

P4AD exists to change that.

What Patients For Affordable Drugs Does

1. Amplifies Patient Voices

Patient stories are the heart of P4AD’s mission. These real experiences reveal the human cost of high drug prices and help lawmakers understand the urgency of reform.

Real Stories, Real Impact

• A retired nurse with psoriatic arthritis paid over $9,000 for Enbrel in 2023. Thanks to the 2022 prescription drug law, her annual out‑of‑pocket costs are now capped at $2,000, saving her more than $8,300.
• Lisa McRipley, living with multiple sclerosis, faced therapy costs exceeding $100,000 a year. The new $2,000 cap will save her at least $6,000 annually and restore her independence.
• Kevin Baker, a 22‑year‑old with Crohn’s disease, relies on medications priced between $1,100 and $14,000 per month before insurance. He believes — and P4AD affirms — that life‑saving medicine is a human right.
• A diabetes patient using Januvia once faced impossible choices to afford her medication. With Medicare negotiation lowering its price, she can now access it consistently and safely.
• A Crohn’s patient dependent on Stelara lives under the shadow of a $25,000 monthly list price, knowing a lapse in coverage could make the drug unattainable.

Policy Reform

P4AD advocates for:

• Medicare negotiation of drug prices
• Ending patent abuses that block generics
• Greater transparency from Pharmacy Benefit Managers (PBMs)
• Addressing extreme launch prices, especially for cell and gene therapies
• Full implementation of the 2022 prescription drug law

Bipartisan Momentum

P4AD works with lawmakers across the political spectrum. Patients from all backgrounds — retirees, students, parents, veterans — share their stories to drive change. Many describe the experience as empowering and transformative.

Why Patients For Affordable Drugs Is Making a Difference

P4AD’s advocacy has already helped secure historic reforms, including the first‑ever Medicare drug price negotiations and caps on insulin and annual out‑of‑pocket costs. Patients who once faced financial ruin now have hope — and a voice.

As one participant put it: “Patients For Affordable Drugs Now has given me the opportunity to have my voice heard by legislators… When they hear my family’s example, they learn — and are hopefully driven to solve the problem.”

Join the Movement

If high drug prices have affected you or someone you love, your story matters. P4AD invites patients nationwide to share their experiences and help push for a fair, affordable prescription drug system.

Learn more, get involved, and add your voice to the fight for affordable medicines.